SCHEMBL8998513

SCHEMBL8998513

C=CP(=O)(O)OO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4947416 0.78 FDPS (0.39)
SCHEMBL27865639 0.73
SCHEMBL12214446 0.73 FDPS (0.50)
SCHEMBL2811015 0.73
SCHEMBL27870580 0.73
SCHEMBL10522686 0.73
SCHEMBL337713 0.73
SCHEMBL10712524 0.73
SCHEMBL8998510 0.71
SCHEMBL10796931 0.71 LPAR3 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996040155-A1 USE OF SPECIFIC ACPA DERIVATIVE (NPC-17742) FOR THE TREATMENT OF ISCHEMIA THE JOHNS HOPKINS UNIVERSITY (US) 1996-12-19 WO disclosed
EP-0639197-B1 EXCITATORY AMINO ACID ANTAGONISTS GUILFORD PHARM INC (US) 1996-09-04 EP disclosed
EP-0639197-A1 EXCITATORY AMINO ACID ANTAGONISTS. GUILFORD PHARM INC (US) 1995-02-22 EP disclosed
EP-0639197-A4 EXCITATORY AMINO ACID ANTAGONISTS. GUILFORD PHARM INC (US) 1994-02-21 EP disclosed
US-5256814-A Anticonvulsant, analgesic, cognition activator SCIOS NOVA INC. (US) 1993-10-26 US disclosed
WO-1992010099-A1 EXCITATORY AMINO ACID ANTAGONISTS NOVA PHARMACEUTICAL CORPORATION (US) 1992-06-25 WO disclosed